Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

About the company

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

16

CEO

Seth Lederman

Exchange

NASDAQ

Website

http://www.tonixpharma.com

$NoneM

Total Revenue

16

Employees

$4.20M

Market Capitalization

-0.09

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12203.10 1376.00 5.20 19.24 43.06
Catalent, Inc. CTLT 10838.26 2872.00 5.44 103.91 3.63
Perrigo Co. Plc PRGO 7574.73 4837.00 1.30 51.67 3.02
Bausch Health Cos., Inc. BHC 6707.00 8597.00 9.36 -3.54 -21.96
Jazz Pharmaceuticals Plc JAZZ 6338.40 2188.00 2.19 23.17 12.81
United Therapeutics Corp. UTHR 5118.72 1443.00 1.78 9.88 36.59
MyoKardia, Inc. MYOK 4243.04 34.00 12.33 -13.69 -201.73
Axsome Therapeutics, Inc. AXSM 2833.95 None 19.23 -31.51 None
Pacira Biosciences, Inc. PCRX 2278.92 435.00 6.11 -5426.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2039.84 335.00 4.68 19.22 31.64
Prestige Consumer Healthcare, Inc. PBH 1850.28 963.00 1.56 13.05 14.77
Revolution Medicines, Inc. RVMD 1738.14 48.00 4.51 -24.55 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1640.55 0.00 4.38 -16.06 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1598.26 440.00 -22.62 18.85 19.14
Innoviva, Inc. INVA 1580.87 285.00 3.74 8.18 66.41
Intercept Pharmaceuticals, Inc. ICPT 1475.20 272.00 -43.90 -4.30 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1313.55 5.00 3.59 -3.09 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1169.64 88.00 -8.21 -4.74 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1077.02 327.00 2.69 21.13 15.90
Endo International Plc ENDP 824.22 3014.00 -1.13 -2.94 -9.09
BellRing Brands, Inc. BRBR 771.22 954.00 -0.42 5.85 13.98
Eagle Pharmaceuticals, Inc. EGRX 671.16 192.00 3.61 266.33 1.29
Assembly Biosciences, Inc. ASMB 669.03 16.00 3.00 -6.73 -601.75
Aerie Pharmaceuticals, Inc. AERI 641.70 79.00 5.09 -3.17 -252.92
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Anika Therapeutics, Inc. ANIK 533.82 125.00 1.84 19.26 22.73
Catalyst Pharmaceuticals, Inc. CPRX 524.30 119.00 5.10 11.95 36.09
Intersect ENT, Inc. XENT 439.36 102.00 4.15 -8.80 -48.61
BioDelivery Sciences International, Inc. BDSI 408.48 130.00 5.84 -55.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 376.08 203.00 1.92 -241.08 -0.67
Albireo Pharma, Inc. ALBO 342.42 11.00 3.48 -4.48 -730.55
MEI Pharma, Inc. MEIP 283.86 5.00 4.89 -7.28 -539.48
Mallinckrodt Plc MNK 209.16 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 163.43 None 2.66 -7.91 None
Marinus Pharmaceuticals, Inc. MRNS 161.60 0.00 6.26 -2.40 None
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.67 1.00 69.00 -5.31 None
Evoke Pharma, Inc. EVOK 89.28 None 31.00 -13.29 None
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Zynerba Pharmaceuticals, Inc. ZYNE 80.50 0.00 1.32 -2.24 -699.94
Adamas Pharmaceuticals, Inc. ADMS 71.68 57.00 -4.57 -0.77 -160.44
CTI BioPharma Corp. CTIC 70.21 3.00 3.13 -1.70 -111.83
Aclaris Therapeutics, Inc. ACRS 68.88 4.00 1.21 -0.50 None
Oramed Pharmaceuticals, Inc. ORMP 63.90 3.00 5.14 -5.00 -464.15
Cassava Sciences, Inc. SAVA 56.43 41.00 2.97 -12.38 76.71
Natural Alternatives International, Inc. NAII 49.77 114.00 0.68 -13.17 -3.19
SCYNEXIS, Inc. SCYX 48.89 0.00 10.27 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.60 47.00 0.99 -10.80 -9.59
Lipocine, Inc. LPCN 43.50 0.00 10.36 -2.90 None
IsoRay, Inc. ISR 38.19 9.00 7.12 -11.40 -36.08
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 35.45 65.00 -2.73 -2.03 -26.74
PLx Pharma, Inc. PLXP 27.18 0.00 -2.60 -2.88 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.24 3.00 2.39 -1.62 -264.21
Regulus Therapeutics, Inc. RGLS 14.49 0.00 1.28 -0.68 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.43 None 1.34 -0.24 None
VIVUS, Inc. VVUS 8.69 73.00 -0.19 -0.29 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.46 19.00 1.02 -2.07 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.76 None 1.80 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.20 None 1.05 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Tonix Pharmaceuticals Plans Massachusetts R&D Facility to Accelerate Clinical Development of Vaccines and Protein-Based Therapeutics

1h ago, source: Business Insider

Tonix's Advanced Development Center Will House Laboratories Dedicated to Process and Analytical DevelopmentNEW YORK, July 07, 2020 (GLOBE ...

Tonix Pharmaceuticals Holding Corp.

5d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Tonix Pharmaceuticals to acquire R&D site in Massachusetts

52m ago, source: Seeking Alpha

Tonix Pharmaceuticals (NASDAQ:TNXP) intends to purchase a 40K square foot facility in Massachusetts for an undisclosed sum.

Tonix Pharmaceuticals Announces Enrollment of Phase 3 RELIEF Trial of TNX-102 SL for Management of Fibromyalgia is Ahead of Schedule

8d ago, source: YAHOO!

NEW YORK, June 29, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that due to faster-than ...

BRIEF-Tonix Pharmaceuticals, Southern Research Announce Expansion Of COVID-19 Vaccine Collaboration

10d ago, source: Reuters

TONIX PHARMACEUTICALS AND SOUTHERN RESEARCH ANNOUNCE EXPANSION OF COVID-19 VACCINE COLLABORATION * TONIX PHARMACEUTICALS ...

Tonix Pharma ahead of schedule in pivotal study of TNX-102 SL in muscle pain disorder

7d ago, source: Seeking Alpha

Due to faster-than-expected enrollment, Tonix Pharmaceuticals Holding (NASDAQ:TNXP) anticipates topline Phase 3 RELIEF results in Q4 2020, rather than Q1 2021 as previously guided.RELIEF is a pivotal ...

Tonix Pharmaceuticals and Southern Research COVID-19 Vaccine Provides a Novel Vector

10d ago, source: Medindia

Tonix Pharmaceuticals and Southern Research have partnered to create a COVID-19 vaccine based on Tonix’s proprietary horsepox vaccine platform. The use of the horsepox vector will be an important ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.